Phase III Randomized Trial of Intravenous Cisplatin Plus a 24- or 96-Hour Infusion of Paclitaxel in Epithelial Ovarian Cancer: A Gynecologic Oncology Group StudyDavid R. Spriggs, Mark G. Hanly, Luis Vaccarello et al.|Journal of Clinical Oncology|2007Cited by 57